The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
CARMELL CORPORATION COM 142922103   263,836 103,061 SH   SOLE   103,061 0 0
DUOLINGO INC CL A COM 26603R106   79,036,902 358,314 SH   SOLE   358,314 0 0
NEUBASE THERAPEUTICS INC COM NEW 64132K201   21,132 46,970 SH   SOLE   46,970 0 0
PREDICTIVE ONCOLOGY INC COM 74039M309   26,413 10,358 SH   SOLE   10,358 0 0
VERA THERAPEUTICS INC CL A 92337R101   692,507 16,060 SH   SOLE   16,060 0 0
INNSUITES HOSPITALITY TRUST SH BEN INT 457919108   13,200 10,000 SH   SOLE   10,000 0 0